- Home
- Publications
- Publication Search
- Publication Details
Title
Notch signaling in serous ovarian cancer
Authors
Keywords
Ovarian serous carcinoma, Notch, Gamma secretase inhibitor, Patient derived xenograft models
Journal
Journal of Ovarian Research
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-11-03
DOI
10.1186/s13048-014-0095-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer
- (2014) Jillian Brechbiel et al. CANCER TREATMENT REVIEWS
- Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth
- (2014) Jolijn W. Groeneweg et al. Frontiers in Oncology
- Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
- (2013) R. J. Kurman ANNALS OF ONCOLOGY
- A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)
- (2013) S Sahebjam et al. BRITISH JOURNAL OF CANCER
- Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
- (2013) Ingrid Espinoza et al. CANCER LETTERS
- Cancer stem cells: A contentious hypothesis now moving forward
- (2013) Michael L. O’Connor et al. CANCER LETTERS
- Activation of the NOTCH Pathway in Head and Neck Cancer
- (2013) W. Sun et al. CANCER RESEARCH
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Stem cells living with a Notch
- (2013) U. Koch et al. DEVELOPMENT
- Notch3 induces epithelial–mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells
- (2013) Nidhi Gupta et al. GYNECOLOGIC ONCOLOGY
- A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
- (2013) Ivan Diaz-Padilla et al. INVESTIGATIONAL NEW DRUGS
- A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
- (2013) Suzanne Richter et al. INVESTIGATIONAL NEW DRUGS
- Signaling cross-talk in the resistance to HER family receptor targeted therapy
- (2013) H Yamaguchi et al. ONCOGENE
- Precursors and pathogenesis of ovarian carcinoma
- (2013) D. Lim et al. PATHOLOGY
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
- (2013) Naoko Takebe et al. PHARMACOLOGY & THERAPEUTICS
- Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry
- (2013) Michael J. Kluk et al. PLoS One
- Notch3 Overexpression as Potential Therapeutic Target in Advanced Stage Chemoresistant Ovarian Cancer
- (2012) Mohammed Tanjimur Rahman et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Ovarian cancer stem cells: Working towards the root of stemness
- (2012) Rosemary Foster et al. CANCER LETTERS
- Defining NOTCH3 Target Genes in Ovarian Cancer
- (2012) X. Chen et al. CANCER RESEARCH
- Evolving concepts in the management of drug resistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance
- (2012) David J. Pinato et al. CANCER TREATMENT REVIEWS
- Notch signaling and neural connectivity
- (2012) Edward Giniger CURRENT OPINION IN GENETICS & DEVELOPMENT
- A phase II study of RO4929097 in metastatic colorectal cancer
- (2012) Jonathan R. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
- (2012) Sergio Marchini et al. EUROPEAN JOURNAL OF CANCER
- Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer
- (2012) Cristina Ivan et al. GYNECOLOGIC ONCOLOGY
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
- (2012) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
- (2012) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models
- (2012) M. Mizuma et al. MOLECULAR CANCER THERAPEUTICS
- Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
- (2012) Vinod Vathipadiekal et al. PLoS One
- Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
- (2012) S. M. McAuliffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The double-edged sword of Notch signaling in cancer
- (2012) Andrew P. South et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification
- (2011) M. G. Cornejo et al. BLOOD
- Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
- (2011) R. Kridel et al. BLOOD
- Biological Roles of the Delta Family Notch Ligand Dll4 in Tumor and Endothelial Cells in Ovarian Cancer
- (2011) W. Hu et al. CANCER RESEARCH
- Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines
- (2011) Jessica G. Drenzek et al. GYNECOLOGIC ONCOLOGY
- Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A
- (2011) Xuan Zhang et al. GYNECOLOGIC ONCOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Cancer Stem Cell and Embryonic Development-Associated Molecules Contribute to Prognostic Significance in Ovarian Cancer
- (2011) Gulperi Oktem et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Evolution of platinum resistance in high-grade serous ovarian cancer
- (2011) Susanna L Cooke et al. LANCET ONCOLOGY
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma
- (2011) N. J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
- (2010) Joon Tae Park et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma
- (2010) Sang G. Jung et al. CANCER SCIENCE
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- Notch 1 signaling is active in ovarian cancer
- (2010) Stephen L. Rose et al. GYNECOLOGIC ONCOLOGY
- Notch Signaling Pathway as a Therapeutic Target in Breast Cancer
- (2010) H. Al-Hussaini et al. MOLECULAR CANCER THERAPEUTICS
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- -Secretase Inhibitors Abrogate Oxaliplatin-Induced Activation of the Notch-1 Signaling Pathway in Colon Cancer Cells Resulting in Enhanced Chemosensitivity
- (2009) R. D. Meng et al. CANCER RESEARCH
- The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
- (2009) Rui Benedito et al. CELL
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer
- (2009) M. E. Mullendore et al. CLINICAL CANCER RESEARCH
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Notch1 expression correlates with tumor differentiation status in ovarian carcinoma
- (2009) Mingyi Wang et al. MEDICAL ONCOLOGY
- Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine
- (2009) S. Fre et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alterations of the Notch pathway in lung cancer
- (2009) Britta Westhoff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion
- (2008) J.-H. Choi et al. CANCER RESEARCH
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Identification ofPbx1, a Potential Oncogene, as a Notch3 Target Gene in Ovarian Cancer
- (2008) Joon T. Park et al. CANCER RESEARCH
- More complicated than it looks: assembly of Notch pathway transcription complexes
- (2008) R A Kovall ONCOGENE
- ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
- (2008) C Osipo et al. ONCOGENE
- The many facets of Notch ligands
- (2008) B D'Souza et al. ONCOGENE
- Structure and function of γ-secretase
- (2008) Alexandra Tolia et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search